The vast majority of nodes evaluated in regions adjacent the primary tumor location in all patients were assigned values of either 0 or 1 (ERCC1−  = 81.5%, ERCC1+  = 83.9%) suggesting limited nodal cancer spread and development. This evidence concerns the gene ERCC1 and cancer.